[go: up one dir, main page]

ATE96999T1 - Verwendung von sertralin zur behandlung von abhaengigkeiten von chemischen stoffen. - Google Patents

Verwendung von sertralin zur behandlung von abhaengigkeiten von chemischen stoffen.

Info

Publication number
ATE96999T1
ATE96999T1 AT90309062T AT90309062T ATE96999T1 AT E96999 T1 ATE96999 T1 AT E96999T1 AT 90309062 T AT90309062 T AT 90309062T AT 90309062 T AT90309062 T AT 90309062T AT E96999 T1 ATE96999 T1 AT E96999T1
Authority
AT
Austria
Prior art keywords
sertraline
treat chemical
chemical addiction
mammal
dependency
Prior art date
Application number
AT90309062T
Other languages
English (en)
Inventor
Peter A Bick
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23584453&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE96999(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pfizer filed Critical Pfizer
Application granted granted Critical
Publication of ATE96999T1 publication Critical patent/ATE96999T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Addiction (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Information Retrieval, Db Structures And Fs Structures Therefor (AREA)
  • Saccharide Compounds (AREA)
  • General Factory Administration (AREA)
AT90309062T 1989-08-30 1990-08-17 Verwendung von sertralin zur behandlung von abhaengigkeiten von chemischen stoffen. ATE96999T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US40064789A 1989-08-30 1989-08-30

Publications (1)

Publication Number Publication Date
ATE96999T1 true ATE96999T1 (de) 1993-11-15

Family

ID=23584453

Family Applications (1)

Application Number Title Priority Date Filing Date
AT90309062T ATE96999T1 (de) 1989-08-30 1990-08-17 Verwendung von sertralin zur behandlung von abhaengigkeiten von chemischen stoffen.

Country Status (16)

Country Link
EP (1) EP0415612B1 (de)
JP (1) JPH0393719A (de)
KR (1) KR930000049B1 (de)
AT (1) ATE96999T1 (de)
AU (1) AU617622B2 (de)
CA (1) CA2024181C (de)
DE (1) DE69004529T2 (de)
DK (1) DK0415612T3 (de)
HU (1) HUT58513A (de)
IE (1) IE63137B1 (de)
IL (1) IL95472A (de)
MY (1) MY106939A (de)
NZ (1) NZ235100A (de)
PH (1) PH27544A (de)
PT (1) PT95118B (de)
ZA (1) ZA906882B (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE96999T1 (de) * 1989-08-30 1993-11-15 Pfizer Verwendung von sertralin zur behandlung von abhaengigkeiten von chemischen stoffen.
SK180499A3 (en) 1997-07-01 2001-08-06 Pfizer Sertraline salts and sustained-release dosage forms of sertraline
KR100366373B1 (ko) * 1997-07-01 2003-01-14 화이자 프로덕츠 인코포레이티드 가용화된 세트랄린 조성물
EE04868B1 (et) * 1998-10-13 2007-08-15 Pfizer Products Inc. Farmatseutiline kompositsioon, mis sisaldab vett mittesisaldavat, vedelat kontsentraati oraalseks manustamiseks, mis sisaldab sertraliini v?i selle farmatseutiliselt vastuv?etava soola kogust ning hte v?i rohkemat vett mittesisaldavat farmatseutilis
US6727283B2 (en) 1998-10-13 2004-04-27 Pfizer Inc. Sertraline oral concentrate
GB2392385A (en) * 2002-09-02 2004-03-03 Cipla Ltd Pharmaceutical preparations comprising a 5HT uptake inhibitor and a homopolymer or copolymer of N-vinyl pyrrolidone

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4536518A (en) * 1979-11-01 1985-08-20 Pfizer Inc. Antidepressant derivatives of cis-4-phenyl-1,2,3,4-tetrahydro-1-naphthalenamine
US4803076A (en) * 1986-09-04 1989-02-07 Pfizer Inc. Controlled release device for an active substance
US4999382A (en) * 1988-10-26 1991-03-12 Massachusetts Institute Of Technology Compositions for treating tobacco withdrawal symptoms and methods for their use
ATE96999T1 (de) * 1989-08-30 1993-11-15 Pfizer Verwendung von sertralin zur behandlung von abhaengigkeiten von chemischen stoffen.
US4962128A (en) * 1989-11-02 1990-10-09 Pfizer Inc. Method of treating anxiety-related disorders using sertraline

Also Published As

Publication number Publication date
EP0415612B1 (de) 1993-11-10
AU6194390A (en) 1991-04-18
PT95118A (pt) 1991-05-22
CA2024181C (en) 1994-11-08
EP0415612A2 (de) 1991-03-06
DK0415612T3 (da) 1993-12-13
CA2024181A1 (en) 1991-03-01
PH27544A (en) 1993-08-18
NZ235100A (en) 1997-05-26
AU617622B2 (en) 1991-11-28
DE69004529D1 (de) 1993-12-16
IE63137B1 (en) 1995-03-22
DE69004529T2 (de) 1994-02-24
IL95472A (en) 1996-05-14
IE903124A1 (en) 1991-03-13
KR910004188A (ko) 1991-03-28
PT95118B (pt) 1997-05-28
HU905683D0 (en) 1991-03-28
JPH0393719A (ja) 1991-04-18
HUT58513A (en) 1992-03-30
EP0415612A3 (en) 1992-02-19
ZA906882B (en) 1992-04-29
MY106939A (en) 1995-08-30
KR930000049B1 (ko) 1993-01-06

Similar Documents

Publication Publication Date Title
DE69012261D1 (de) Verwendung von Sertralin zur Behandlung verfrühter Ejakulation.
DE69033903D1 (de) Verwendung von Sertraline zur Herstellung eines Arzneimittels zur Behandlung von obsessiv-kompulsiven Erkrankungen
DE3779149D1 (de) Galanthamin oder dessen analoge zur behandlung der alzheimerschen krankheit.
ATE411026T1 (de) Mittel zur behandlung der alzheimer-krankheit
ATE96999T1 (de) Verwendung von sertralin zur behandlung von abhaengigkeiten von chemischen stoffen.
DE69304843D1 (de) Methode zur Behandlung von Haarausfall
ATE281841T1 (de) Verfahren zur herstellung von mikania extrakten enthaltend mikanolide und dihydromikanolide und verwendung in der behandlung proliferativer erkrankungen
ATE235237T1 (de) Sertralin zur behandlung von post-myocard-infarkt-patienten
DE68926222D1 (de) Verwendung von 1,2,3,4-Tetrahydroacridinen zur Behandlung von AIDS, sowie Verbindungen
DE69830811D1 (de) Verwendung von Oxazolidinonderivaten zur Behandlung von Psoriasis

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee